Citations

Mayo Clinic

Showing 10 of 108599 citations.

Relationships among quality of life and survival in anemic patients with advanced cancer undergoing chemotherapy
Sloan, Jeff A. , Schaefer, Paul, Novotny, Paul J. , Silberstein, Peter T., Beardon, J. D., Allred, Jacob B., Mailliard, J A, Loprinzi, Charles L. , Witzig, Thomas E.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 6027-6027

10.1200/jco.2005.23.16_suppl.6027 Get It

SWOG/Intergroup 9623: A phase III comparison of intensive sequential chemotherapy to high dose chemotherapy and autologous hematopoietic progenitor cell support (AHPCS) for primary breast cancer in women with ≥4 involved axillary lymph nodes
Bearman, SI, Green, S., Barlow, William, Hudis, Clifford A. , Hortobágyi, G. N., Livingston, R., Martino, Silvana, Green, S., Gralow, Julie R. , Wolff, Antonio C. , Ingle, James N. , Livingston, R. B.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 572-572

10.1200/jco.2005.23.16_suppl.572 Get It

Retrospective review of adjuvant chemotherapy for esthesioneuroblastoma
Bernold, D. M., Foote, Robert L. , Link, Michael J., Moynihan, Timothy J. , Buckner, Jan C. , Khurana, Vikas , Giannini, Caterina

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 5534-5534

10.1200/jco.2005.23.16_suppl.5534 Get It

Zoledronic acid (ZA) effectively inhibits cancer treatment-induced bone loss (CTIBL) in postmenopausal women (PMW) with early breast cancer (BCa) receiving adjuvant letrozole (Let): 12 mos BMD results of the Z-FAST trial
Brufsky, Adam , Harker, W G, Carroll, Robert R., Tan-Chiu, Elizabeth, Seidler, C. W., Lacerna, Leo V., Thomas, E. W. Prosser, Perez, Edith A. , Beck, J. Thaddeus , Thomas, E., Brufsky, Adam M

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 533-533

10.1200/jco.2005.23.16_suppl.533 Get It

Phase II evaluation of dacarbazine (D), mitomycin-C (M), doxorubicin (A) and cisplatin (P) (DMAP) plus sargramostim (GM-CSF) in the treatment of advanced, persistent, or recurrent leiomyosarcoma of the uterus: A Gynecologic Oncology Group (GOG) study
Long, Harry J., Blessing, John A., Sorosky, Joel I.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 5077-5077

10.1200/jco.2005.23.16_suppl.5077 Get It

Hematologic and cytogenetic (CTG) response to lenalidomide (CC-5013) in patients with transfusion-dependent (TD) myelodysplastic syndrome (MDS) and chromosome 5q31.1 deletion: Results of the multicenter MDS-003 Study
Dewald, G, Bennett, Jeffrey, Giagounadis, A., Raza, Azra , Feldman, E., Powell, Benjamin, Greenberg, Peter L. , Zeldis, Jerome B. , List, Alan F. , Knight, Robert

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 5-5

10.1200/jco.2005.23.16_suppl.5 Get It

Salvage brachytherapy and short-term androgen deprivation therapy for locally recurrent prostate cancer after external beam irradiation
Wong, W. , Buskirk, S.J., Karin, Putu Ayu Emmy Savitri , Schild, Steven E.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4788-4788

10.1200/jco.2005.23.16_suppl.4788 Get It

Preliminary results of a phase II trial of gefitinib in progressive metastatic neuroendocrine tumors (NET): A Phase II Consortium (P2C) study
Hobday, Timothy J. , Mahoney, M. R. , Erlichman, Charles , Lloyd, R, Kim, G., Mulkerin, Daniel , Fitch, Tom R., Donehower, Ross C. , Picus, Joel

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4083-4083

10.1200/jco.2005.23.16_suppl.4083 Get It

A phase II trial of CPT-11 in patients (pts) with advanced gastric or gastroesophageal (GE) junction adenocarcinoma (ADCA): A clinical and pharmacodynamic evaluation. A North Central Cancer Treatment Group (NCCTG) Study
Erlichman, Charles , Goldberg, Richard M. , Mahoney, M. R. , Kabat, Brian, Huntington, Jefrey L., Sebo, Thomas J., Egner, James R., Pitot, Henry C., Sargent, Daniel J. , Kaufmann, Scott H.

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 4026-4026

10.1200/jco.2005.23.16_suppl.4026 Get It

Safety of bevacizumab (BV) among patients (pts) receiving first-line chemotherapy (CT) for metastatic colorectal cancer (mCRC): Preliminary results from a larger registry in the U.S
Kozloff, M., Cohn, Allen Lee, Christiansen, N., Flynn, Patrick J. , Kabbinavar, Fairooz F. , Robles, Robert, Sarkar, Somnath , Hambleton, J., Yood, Marianne Ulcickas , Grothey, Axel

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 3566-3566

10.1200/jco.2005.23.16_suppl.3566 Get It